LENZ Therapeutics, Inc. (LENZ) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$91.14M | -55.5% |
| 2024 | -$58.61M | +19.1% |
| 2023 | -$72.43M | +31.4% |
| 2022 | -$105.64M | -74.8% |
| 2021 | -$60.44M | -347.7% |
| 2020 | -$13.50M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$91.14M | -55.5% |
| 2024 | -$58.61M | +19.1% |
| 2023 | -$72.43M | +31.4% |
| 2022 | -$105.64M | -74.8% |
| 2021 | -$60.44M | -347.7% |
| 2020 | -$13.50M | — |